Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
62.11
+6.24 (11.17%)
At close: Mar 9, 2026, 4:00 PM EDT
62.07
-0.04 (-0.06%)
After-hours: Mar 9, 2026, 7:02 PM EDT
Spruce Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 48.91 | 38.75 | 96.34 | 24.49 | 42.75 | Upgrade
|
| Short-Term Investments | - | - | - | 54.59 | 46.22 | Upgrade
|
| Cash & Short-Term Investments | 48.91 | 38.75 | 96.34 | 79.08 | 88.97 | Upgrade
|
| Cash Growth | 26.20% | -59.77% | 21.83% | -11.12% | -43.39% | Upgrade
|
| Prepaid Expenses | 0.35 | 3.18 | 3.88 | 3.32 | 2.53 | Upgrade
|
| Restricted Cash | - | - | - | 0.22 | - | Upgrade
|
| Other Current Assets | 2.85 | 2.28 | 1.97 | 1 | 0.4 | Upgrade
|
| Total Current Assets | 52.11 | 44.21 | 102.18 | 83.61 | 91.9 | Upgrade
|
| Property, Plant & Equipment | 0.67 | 0.93 | 1.18 | 1.4 | 1.48 | Upgrade
|
| Long-Term Investments | - | - | - | - | 32.46 | Upgrade
|
| Other Long-Term Assets | 0.24 | 0.07 | 0.58 | 0.64 | 0.65 | Upgrade
|
| Total Assets | 53.02 | 45.21 | 103.95 | 85.65 | 126.49 | Upgrade
|
| Accounts Payable | 0.94 | 1.3 | 3.33 | 1.43 | 2.82 | Upgrade
|
| Accrued Expenses | 9.14 | 12.05 | 14.35 | 9.26 | 5.69 | Upgrade
|
| Current Portion of Long-Term Debt | - | 1.62 | 1.62 | 1.62 | - | Upgrade
|
| Current Portion of Leases | - | 0.28 | 0.25 | 0.14 | 0.36 | Upgrade
|
| Current Unearned Revenue | - | - | 4.91 | - | - | Upgrade
|
| Total Current Liabilities | 10.09 | 15.25 | 24.47 | 12.45 | 8.87 | Upgrade
|
| Long-Term Debt | - | 0.12 | 1.72 | 3.29 | 4.88 | Upgrade
|
| Long-Term Leases | 0.42 | 0.74 | 1.02 | 1.26 | 1.29 | Upgrade
|
| Other Long-Term Liabilities | - | 0.28 | 0.24 | 0.16 | 0.07 | Upgrade
|
| Total Liabilities | 10.51 | 16.39 | 27.44 | 17.16 | 15.12 | Upgrade
|
| Common Stock | - | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 331.75 | 279.09 | 273.74 | 218.35 | 214.69 | Upgrade
|
| Retained Earnings | -289.23 | -250.27 | -197.23 | -149.31 | -103.13 | Upgrade
|
| Comprehensive Income & Other | - | - | - | -0.56 | -0.18 | Upgrade
|
| Total Common Equity | 42.52 | 28.82 | 76.51 | 68.49 | 111.37 | Upgrade
|
| Shareholders' Equity | 42.52 | 28.82 | 76.51 | 68.49 | 111.37 | Upgrade
|
| Total Liabilities & Equity | 53.02 | 45.21 | 103.95 | 85.65 | 126.49 | Upgrade
|
| Total Debt | 0.42 | 2.77 | 4.61 | 6.32 | 6.53 | Upgrade
|
| Net Cash (Debt) | 48.49 | 35.99 | 91.73 | 72.76 | 82.44 | Upgrade
|
| Net Cash Growth | 34.73% | -60.77% | 26.07% | -11.74% | -45.32% | Upgrade
|
| Net Cash Per Share | 63.25 | 65.41 | 178.65 | 231.95 | 264.66 | Upgrade
|
| Filing Date Shares Outstanding | 1.37 | 0.56 | 0.55 | 0.53 | 0.31 | Upgrade
|
| Total Common Shares Outstanding | 1.37 | 0.56 | 0.55 | 0.31 | 0.31 | Upgrade
|
| Working Capital | 42.03 | 28.96 | 77.72 | 71.16 | 83.02 | Upgrade
|
| Book Value Per Share | 30.99 | 51.18 | 139.85 | 217.64 | 355.56 | Upgrade
|
| Tangible Book Value | 42.52 | 28.82 | 76.51 | 68.49 | 111.37 | Upgrade
|
| Tangible Book Value Per Share | 30.99 | 51.18 | 139.85 | 217.64 | 355.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.